Search Page

1

Cite

Share

Pharmacy data in the VA health care system.

Smith MW, Joseph GJ. Smith MW, et al. Among authors: joseph gj. Med Care Res Rev. 2003 Sep;60(3 Suppl):92S-123S. doi: 10.1177/1077558703256726. Med Care Res Rev. 2003. PMID: 15095548 Review.

Cite

Share

2

Cite

Share

Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States.

Volk ML, Burne R, Guérin A, Shi S, Joseph GJ, Heimanson Z, Ahmad M. Volk ML, et al. Among authors: joseph gj. J Med Econ. 2021 Jan-Dec;24(1):202-211. doi: 10.1080/13696998.2021.1877148. J Med Econ. 2021. PMID: 33464935 Free article.

Cite

Share

3

Cite

Share

Angiosarcoma of the Heart Presenting as Subacute Pericarditis.

Joseph AL, Wilklow FE, Olivier JJ, Joseph GJ, Glancy DL. Joseph AL, et al. Among authors: joseph gj. Am J Cardiol. 2017 Mar 15;119(6):941-943. doi: 10.1016/j.amjcard.2016.11.049. Epub 2016 Dec 18. Am J Cardiol. 2017. PMID: 28043397

Cite

Share

4

Cite

Share

Intracranial adenoid cystic carcinoma: case report and review of the literature.

Alleyne CH, Bakay RA, Costigan D, Thomas B, Joseph GJ. Alleyne CH, et al. Among authors: joseph gj. Surg Neurol. 1996 Mar;45(3):265-71. doi: 10.1016/0090-3019(95)00235-9. Surg Neurol. 1996. PMID: 8638224 Review.

Cite

Share

5

Cite

Share

Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States.

Stein EM, Yang M, Guerin A, Gao W, Galebach P, Xiang CQ, Bhattacharyya S, Bonifacio G, Joseph GJ. Stein EM, et al. Among authors: joseph gj. Health Qual Life Outcomes. 2018 Sep 21;16(1):193. doi: 10.1186/s12955-018-1013-9. Health Qual Life Outcomes. 2018. PMID: 30241538 Free PMC article.

Cite

Share

6

Cite

Share

Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective.

Ritchie EK, Latremouille-Viau D, Guerin A, Pivneva I, Habucky K, Ndife B, Joseph GJ, Atallah EL. Ritchie EK, et al. Among authors: joseph gj. Leuk Lymphoma. 2019 Jun;60(6):1476-1484. doi: 10.1080/10428194.2018.1538510. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668234

Cite

Share

7

Cite

Share

Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations.

Stein EM, Bonifacio G, Latremouille-Viau D, Guerin A, Shi S, Gagnon-Sanschagrin P, Briggs O, Joseph GJ. Stein EM, et al. Among authors: joseph gj. J Med Econ. 2018 Jun;21(6):556-563. doi: 10.1080/13696998.2018.1425209. Epub 2018 Jan 22. J Med Econ. 2018. PMID: 29304724 Free article.

Cite

Share

8

Cite

Share

Cost and effectiveness of biologics for rheumatoid arthritis in a commercially insured population.

Curtis JR, Chastek B, Becker L, Quach C, Harrison DJ, Yun H, Joseph GJ, Collier DH. Curtis JR, et al. Among authors: joseph gj. J Manag Care Spec Pharm. 2015 Apr;21(4):318-29. doi: 10.18553/jmcp.2015.21.4.318. J Manag Care Spec Pharm. 2015. PMID: 25803765

Cite

Share

9

Cite

Share

Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States.

Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Tang DH, Pivneva I, Gagnon-Sanschagrin P, Joseph GJ. Seiter K, et al. Among authors: joseph gj. Adv Ther. 2018 Oct;35(10):1671-1685. doi: 10.1007/s12325-018-0772-3. Epub 2018 Aug 28. Adv Ther. 2018. PMID: 30155792

Cite

Share

10

Cite

Share

Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis.

Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Harrison DJ, Joseph GJ, Sauer BC. Cannon GW, et al. Among authors: joseph gj. J Rheumatol. 2014 Oct;41(10):1935-43. doi: 10.3899/jrheum.140164. Epub 2014 Aug 15. J Rheumatol. 2014. PMID: 25128516 Free article.

Cite

Share